Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to impro...
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
This is an international, open-label, stratified randomized controlled trial with Bayesian adaptive stopping rules to compare the effects of therapeutic-dose heparin vs. usual care pharmacological thr...
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on the prevention of death or progression t...
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants
The objective of the study is to evaluate the safety, tolerability, and immunogenicity of 4 injections of VAX-31 (at 4 dose levels) compared to PCV20 in infants at 2, 4, 6, and 12-15 months of age, in...
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
The main objective of the trial is to assess the efficacy and safety of trimodulin as adjunctive treatment to standard of care (SoC) compared to placebo plus SoC in adult hospitalized subjects with sC...
Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.
A Phase 2a, randomized, double-blind, placebo-controlled, multiple ascending dose study in patients who are hospitalized with presumed pneumonia requiring supplemental oxygen therapy. The purpose of t...
Top Cities for Pneumonia Clinical Trials
Pneumonia clinical trials are recruiting across 47 cities. Here are the cities with the most active studies:
About Pneumonia
Pneumonia is an infection that inflames the air sacs in one or both lungs, which may fill with fluid or pus. It can range from mild to life-threatening. Treatment depends on the cause and severity, including antibiotics, antivirals, and supportive care.
Clinical trials are advancing new treatments for pneumonia. Currently, 6 studies are recruiting a combined 28,480 participants across the United States. Research is being conducted by 6 organizations including UMC Utrecht, University of Manitoba, AstraZeneca and 3 others.
2026 Pneumonia Research Landscape
As of March 2026, the pneumonia clinical trial landscape includes 6 actively recruiting studies across 47 cities in the United States. These studies are collectively seeking 28,480 participants, with an average enrollment target of 4,747 per study.
Research is being led by 6 different organizations, including UMC Utrecht, University of Manitoba, AstraZeneca, Vaxcyte, Inc., Biotest, and 1 others.
Geographically, pneumonia trials are most concentrated in Jacksonville, Florida (2 trials); Augusta, Georgia (2 trials); Chicago, Illinois (2 trials); Columbus, Ohio (2 trials); Portland, Oregon (2 trials) and 7 other cities.
Featured Pneumonia Studies
Highlighted recruiting studies for pneumonia, selected by enrollment size and research scope.
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to improve outcome of patients admitted to intensive care with community-acquired pneumonia. In addition, REMAP-CAP provides and adaptive research platform for evaluation of multiple treatment modalities in ...
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
This is an international, open-label, stratified randomized controlled trial with Bayesian adaptive stopping rules to compare the effects of therapeutic-dose heparin vs. usual care pharmacological thromboprophylaxis on outcomes in patients admitted to hospital with community acquired pneumonia (CAP).
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on the prevention of death or progression to IMV/ECMO.
Frequently Asked Questions About Pneumonia Clinical Trials
Are there pneumonia clinical trials near me?
Yes, there are 6 pneumonia clinical trials currently recruiting across 47+ cities in the United States, including Jacksonville, Florida; Augusta, Georgia; Chicago, Illinois. Browse the studies above to find one at a location convenient for you.
How do I join a pneumonia clinical trial?
To join a pneumonia clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are pneumonia clinical trials free?
Yes, participation in pneumonia clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of pneumonia treatments are being studied?
Current pneumonia clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 6 research organizations.
Is it safe to participate in pneumonia clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 2, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 2, 2026 · Data from ClinicalTrials.gov